-
Amid heightened volatility in the Middle East, prices are rising and energy constraints are being felt across Asia-Pacific. Leveraging learnings from COVID-19 and the Ukraine-Russia conflict, how can the region balance national food security concerns with global food flows? And how can we maintain food safety and affordable nutrition in such an unstable environment?
-
As global shocks ripple through supply chains, join a leading economist to unpack the latest risk signals and industry shifts. We’ll identify where pressure is building, where growth opportunities remain, and how regional competitiveness is evolving.
-
Food and nutrition priorities are in flux as costs rise and risks intensify. Where are objectives aligning or diverging across borders, and which regional cooperation models are best positioned to build resilience? What role will Singapore play in this shifting landscape?
-
ASEAN member states are pushing ahead with a new five‑year plan for resilient, regenerative agriculture - but is regen ag really the silver bullet it’s made out to be? What funding, capacity building, and market access models are still missing to turn policy ambition into real change on the ground?
-
From calories to micronutrients, the definition of food security is shifting - just as affordability comes under pressure. Where do CPG and ingredient brands see the biggest gaps in nutrition outcomes, and how can access to safe, high‑value nutrition be expanded across income groups and life stages in Asia?
-
As the main stage pauses, these fast-paced panels and interactive roundtables in breakout rooms will explore what it takes to bring the regenerative agriculture solutions stack – from bio-inputs to precision tools - to scale. Hear practical insights from agribusinesses, technology providers, start-ups, and investors, and join the conversation to surface new ideas, share challenges, and co-create solutions with local impact.
-
As the main stage pauses, these fast-paced panels and interactive roundtables in breakout rooms will explore foodtech innovations enabling healthy longevity - from functional F&B for senior and women’s health to GLP-1s. Hear practical insights from CPGs, ingredient brands, retailers, start-ups, and investors, and join the conversation to surface new ideas, share challenges, and co-create solutions with local impact.
-
As market‑access regulation tightens and Scope 3 reporting rises in importance ahead of 2030 climate targets, food supply chains are facing growing pressure. What’s holding back progress in building reliable data pipelines and measurement standards across complex, multi‑tier systems? And how can CPGs and agribusinesses scale new technologies and farmer support programmes to deliver traceability, compliance, and real accountability?
-
The pre‑summit Investment Forum unpacked how a new capital stack is emerging across venture, catalytic, and non‑dilutive funding streams. As capital becomes more selective, where is liquidity really coming from - and which investment and collaboration models are best positioned to deliver growth and impact across Asia‑Pacific?
-
Breakthrough science only creates value when it achieves real‑world adoption, yet innovation continues to outpace deployment. Where does the path from lab to market break down, and which structural enablers are needed to reduce cost, drive commercial readiness, and accelerate adoption?
-
From weight management and healthy longevity to personalised nutrition, food and nutrition innovation is accelerating at unprecedented speed - but what are consumers actually willing to pay for? As scrutiny rises fuelled by the ongoing UPF debate and recent safety concerns, how do perceptions around processing, quality, and health claims shape what gets accepted or rejected? And how can brands align product design, positioning, and pricing with real‑world market dynamics to move from initial interest to repeat adoption?
-
National food policy directives shape where biomanufacturing capacity scales - success depends on infrastructure, incentives, and ecosystem maturity. From precision fermentation to cell-based technologies, which platforms and ingredients are best positioned to move from pilot to commercial production? And how are countries and companies rethinking regulatory pathways, CapEx, and manufacturing strategy?
-
A curated group of early and growth stage companies take the stage to showcase breakthrough science and commercial traction. Join these rapid-fire pitches to hear what technologies are translating into scalable solutions and which founders are turning innovation into real-world impact?
-
An interactive roundtable format brings together senior decision-makers, investors, and innovators for candid discussion. Join focused conversations designed to spark partnerships, surface shared challenges, and unlock new opportunities.
-
Biologicals are gaining momentum amid fertiliser volatility and climate risk, yet adoption remains uneven due to inconsistent performance. What standards and benchmarks are needed to prove real‑world reliability and repeatability? And how do demonstration plots and peer networks - from field days to WhatsApp groups - build the trust needed for widespread adoption?
-
Robotics and precision tools are advancing fast, but cost, interoperability, and risk are still holding back widespread adoption. How can solutions be integrated into existing workflows, and what lessons have emerged around simplicity and compatibility across crops and systems? When does ownership make sense versus “as‑a‑service” models?
-
Bringing together senior policymakers from across the region, this ministerial forum will explore how governments are supporting the adoption of new technologies and practices across agriculture and forestry. From capacity building and infrastructure to policy alignment and regional cooperation, the discussion will focus on what it takes to move innovation beyond pilots and into real‑world impact. More information on themes and formats to be announced soon.
-
AI is rapidly reshaping how agri-food innovation is scoped, funded, and delivered, forcing leaders to rethink what gets built, backed, and scaled. As capabilities mature in a margin-constrained environment, how will AI redefine R&D priorities, compress development timelines, and reshape the cost and risk profile of innovation pipelines in the next 3, 5, and 10 years?
-
Biomanufacturing is shifting food and agriculture from land‑intensive systems toward controlled, tech‑driven production. But as the sector moves beyond hype, where across inputs and ingredients is it delivering genuine functional differentiation and commercial value?
-
AI‑led discovery is transforming how candidates for inputs and seeds are identified and validated, shifting R&D from trial‑and‑error to predictive precision. How are LLMs using large biological datasets to accelerate trait discovery and de‑risk breakthroughs before development even begins?
Stick around for a product tasting!
-
AI is pushing nutraceutical development toward biomarker-driven, evidence-backed outcomes – but scrutiny is rising. How quickly can bioactives with defined modes of action reach market, and can the industry move from marketing claims to measurable, defensible performance at scale?
-
AI and biomanufacturing are redefining how ingredients are created - shifting from novelty to measurable performance. Which new proteins and functional compounds show promise, where do data blind spots persist, and what is commercially viable across biomanufacturing platforms such as precision fermentation and cell-based tech? Where is there a genuine market need for lab-grown ingredients versus optimised natural bioactives?
-
Advances in robotics, precision tools, and digital advisory are transforming agriculture, but real‑world performance still varies widely across crops, geographies, and farming systems in Asia‑Pacific. Which technologies are delivering measurable gains on the ground, how are AI‑guided diagnostics removing maintenance barriers, and what gaps in data collection, aggregation, and labelling still limit R&D and innovation?
-
Consumers are increasingly taking control – using LLMs and digital tools to interpret their own health and nutrition data. But can brands keep up? From glucose to sleep, wearable‑derived biomarker insights may hold the key, allowing CPGs to design personalised products that meet consumers where they are and actually deliver in practice.
-
Following a funding reset, investors are redefining what “credible innovation” looks like in agtech and foodtech. What has changed in how teams, governance, and revenue roadmaps are evaluated? How are investors separating durable, value‑creating capabilities from AI hype, and what does this mean for fundraising, capital discipline, and exit strategies?